BX Swiss TOP 30 CHF
1.228,04
PKT
-12,73
PKT
-1,03
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
25.09.18 | Novartis Neutral | UBS AG | |
25.09.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
25.09.18 | Holcim Hold | Kepler Cheuvreux | |
25.09.18 | Swiss Re Hold | Commerzbank AG | |
25.09.18 | Roche overweight | JP Morgan Chase & Co. | |
25.09.18 | Nestlé overweight | JP Morgan Chase & Co. | |
25.09.18 | Givaudan overweight | JP Morgan Chase & Co. | |
24.09.18 | Nestlé market-perform | Bernstein Research | |
24.09.18 | Givaudan verkaufen | Bernstein Research | |
20.09.18 | Novartis Equal weight | Barclays Capital | |
20.09.18 | Nestlé Neutral | BNP PARIBAS | |
20.09.18 | Nestlé overweight | JP Morgan Chase & Co. | |
20.09.18 | Nestlé buy | Goldman Sachs Group Inc. | |
20.09.18 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
19.09.18 | Roche Neutral | UBS AG | |
19.09.18 | Nestlé Underperform | Credit Suisse Group | |
18.09.18 | UBS buy | Deutsche Bank AG | |
18.09.18 | UBS Hold | Deutsche Bank AG | |
14.09.18 | Roche Neutral | UBS AG | |
14.09.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
14.09.18 | ABB (Asea Brown Boveri) buy | Société Générale Group S.A. (SG) | |
12.09.18 | Swiss Re Sell | UBS AG | |
12.09.18 | UBS buy | Goldman Sachs Group Inc. | |
12.09.18 | UBS Neutral | Goldman Sachs Group Inc. | |
11.09.18 | Novartis buy | Citigroup Corp. | |
11.09.18 | Novartis Neutral | UBS AG | |
11.09.18 | Roche Underperform | BNP PARIBAS | |
11.09.18 | Novartis Neutral | BNP PARIBAS | |
10.09.18 | UBS buy | Société Générale Group S.A. (SG) | |
10.09.18 | UBS buy | Société Générale Group S.A. (SG) | |
10.09.18 | Roche Neutral | Merrill Lynch & Co., Inc. | |
10.09.18 | Novartis buy | Merrill Lynch & Co., Inc. | |
10.09.18 | UBS overweight | JP Morgan Chase & Co. | |
10.09.18 | UBS overweight | JP Morgan Chase & Co. | |
10.09.18 | Holcim Hold | Deutsche Bank AG | |
10.09.18 | UBS Equal weight | Barclays Capital | |
07.09.18 | Swiss Re overweight | Barclays Capital | |
07.09.18 | Zurich Insurance Equal weight | Barclays Capital | |
07.09.18 | Novartis buy | Jefferies & Company Inc. | |
07.09.18 | Roche buy | Jefferies & Company Inc. |